Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SariPRO: Sarilumab PROs in RA
NCT03449758Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2018
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of sarilumab in rheumatoid arthritis (RA), sponsored by Sanofi. Started Mar 2018; status: completed.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03449758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03449758.